Ae. Errasti et al., Characterization of alpha(1)-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein, BR J PHARM, 126(2), 1999, pp. 437-442
1 The present study attempted to characterize pharmacologically the subtype
s of alpha-adrenoceptors mediating contractions in human umbilical vein (HU
V).
2 HUV rings were mounted in isolated organ baths and cumulative concentrati
on-response curves were constructed for the alpha-adrenoceptor agonists phe
nylephrine and adrenaline. Adrenaline was more potent than phenylephrine (p
D(2) = 7.29 and 6.04 respectively).
3 Isoproterenol exhibited no agonism on KCl pre-contracted HUV rings. Propr
anolol (1 mu M) and rauwolscine (0.1 mu M) did not affect the concentration
-response curves to adrenaline. These results demonstrate the lack of invol
vement of functional beta- or alpha(2)-adrenoceptors in adrenaline-induced
vasoconstriction.
4 The non subtype selective alpha(1)-adrenoceptor antagonist prazosin was e
valuated on phenylephrine and adrenaline concentration-response curves. The
effects of the competitive alpha(1A) and alpha(1D)-adrenoceptor antagonist
s, 5-methyl urapidil and BMY 7378 and the irreversible alpha(1B) selective
compound chloroethylclonidine (CEC) were also evaluated on adrenaline conce
ntration-response curves.
5 The potencies of prazosin against responses mediated by adrenaline (pA(2)
= 10.87) and phenylephrine (pA(2) = 10.70) indicate the involvement of pra
zosin-sensitive functional alpha(1)-adrenoceptor subtype in vasoconstrictio
n of the HUV.
6 The potencies of 5-methyl urapidil (pA(2) = 6.70) and BMY 7378 (pA(2) = 7
.34) were not consistent with the activation of an alpha(1A)- or alpha(1D)-
adrenoceptor population.
7 Exposure to a relatively low CEC concentration (3 mu M) abolished the max
imum response to adrenaline suggesting that this response was mediated by a
n alpha(1B)-adrenoceptor subtype.
8 We conclude that HUV express a prazosin-sensitive functional alpha(1)-adr
enoceptor resembling the alpha(1B)-subtype according with the low pA(2) val
ues for both 5-methyl urapidil and BMY 7378 and the high sensitivity to CEC
.